The essence of the dissent is that the Prostate Specific Antigen test is unreliable at detecting a malignancy and that there is no proof that treating most prostate cancers is effective.
Prostate cancer is almost universal.
There is no conclusive evidence that beating prostate cancer lengthens life. The PSA test is unreliable. Even though the American Urological Association recommends the PSA test, the equally prestigious U.S. Preventive Services Task Force does not. These are compelling arguments. However, the American Cancer Society recommends testing and treatment for prostate cancer, because 179,000 men in the U.S. will learn they have the disease this year, and 37,000 will die from it.